EMERGO SUMMARY OF KEY POINTS: FDA draft guidance clarifies how Third Party Review process aligns with the Medical Device Single Audit Program (MDSAP). This guidance complements several IMDRF MDSAP documents issued in 2013, 2014 and 2015. MDSAP implementation set for January 2017; US, Australia, Brazil, Canada and Japan are participating.